Your browser doesn't support javascript.
loading
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants.
Panikkar, Archana; Lineburg, Katie E; Raju, Jyothy; Chew, Keng Yih; Ambalathingal, George R; Rehan, Sweera; Swaminathan, Srividhya; Crooks, Pauline; Le Texier, Laetitia; Beagley, Leone; Best, Shannon; Solomon, Matthew; Matthews, Katherine K; Srihari, Sriganesh; Neller, Michelle A; Short, Kirsty R; Khanna, Rajiv; Smith, Corey.
Affiliation
  • Panikkar A; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Lineburg KE; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Raju J; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Chew KY; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
  • Ambalathingal GR; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Rehan S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Swaminathan S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Crooks P; Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Le Texier L; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Beagley L; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Best S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Solomon M; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Matthews KK; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Srihari S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Neller MA; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Short KR; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Khanna R; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
  • Smith C; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia Queensland, Australia.
PLoS Pathog ; 18(2): e1010339, 2022 02.
Article in En | MEDLINE | ID: mdl-35157735
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / SARS-CoV-2 / HLA Antigens Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: PLoS Pathog Year: 2022 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / SARS-CoV-2 / HLA Antigens Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: PLoS Pathog Year: 2022 Type: Article Affiliation country: Australia